Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders
Confluence Pharmaceuticals has raised $200K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.
Confluence Pharmaceuticals's investors include Elevate Ventures, IU Ventures, Purdue Research Foundation, Indiana University Philanthropic Venture Fund.
Confluence Pharmaceuticals is headquartered in Indianapolis, United States.
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders
Confluence Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Confluence Pharmaceuticals — Funding & Investors." VCBacked, June 17, 2022, https://www.vcbacked.co/company/confluence-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2022). Confluence Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/confluence-pharmaceuticals
{{cite web |title=Confluence Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/confluence-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated